TENX

Tenax Therapeutics Stock Price

0.92
0.0173 (1.92%)
Upgrade to Real-Time
Afterhours (Closed)
0.9027
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Tenax Therapeutics Inc TENX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0027 0.3% 0.9027 0.902 0.98 0.9399 0.90 00:00:01
Bid Price Ask Price Spread Spread % News
0.90 1.02 0.12 11.76% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
571 224,698 $ 0.934491 $ 209,978 2,393,700 0.25 - 2.90
Last Trade Time Type Quantity Stock Price Currency
17:55:58 2 $ 0.92 USD

Tenax Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.32M 9.22M 9.18M $ - $ - -1.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Tenax Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TENX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.031.04010.860.9325458319,104-0.1273-12.36%
1 Month1.451.600.861.23452,783-0.5473-37.74%
3 Months0.63212.900.5100991.461,397,3090.270642.81%
6 Months1.422.900.251.40690,181-0.5173-36.43%
1 Year1.372.900.251.39371,165-0.4673-34.11%
3 Years14.8015.500.253.67407,139-13.90-93.9%
5 Years73.0679.600.259.35361,384-72.16-98.76%

Tenax Therapeutics Description

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The company develops novel product candidates such as Levosimendan that have the potential to address various critical care conditions with a high unmet medical need. Its drugs help in the reduction of morbidity and mortality in cardiac surgery patients. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure.


Your Recent History
NASDAQ
TENX
Tenax Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.